A comparative proteomics analysis of peritoneal dialysate before and after the occurrence of peritonitis episode by mass spectrometry

碩士 === 國立成功大學 === 環境醫學研究所 === 101 === Peritoneal dialysis (PD) is one of the therapeutic options for end-stage renal disease (ESRD). The peritoneal membrane is immersed in a high glucose concentration of the peritoneal dialysate which in long term may cause structural and functional damage to the pe...

Full description

Bibliographic Details
Main Authors: Sing-SingTing, 陳成欣
Other Authors: Pao-Chi Liao
Format: Others
Language:en_US
Published: 2013
Online Access:http://ndltd.ncl.edu.tw/handle/11559201736443628725
id ndltd-TW-101NCKU5520006
record_format oai_dc
spelling ndltd-TW-101NCKU55200062015-10-13T22:01:26Z http://ndltd.ncl.edu.tw/handle/11559201736443628725 A comparative proteomics analysis of peritoneal dialysate before and after the occurrence of peritonitis episode by mass spectrometry 以蛋白質體學及質譜儀分析方法比較在發生腹膜炎前後腹膜透析液中的差異蛋白質表現 Sing-SingTing 陳成欣 碩士 國立成功大學 環境醫學研究所 101 Peritoneal dialysis (PD) is one of the therapeutic options for end-stage renal disease (ESRD). The peritoneal membrane is immersed in a high glucose concentration of the peritoneal dialysate which in long term may cause structural and functional damage to the peritoneal membrane. Peritonitis is one of the major complications of PD which will accelerate the damage of peritoneal membrane by increasing the peritoneal permeability and decrease the ultrafiltration efficiency. Finally it will cause the peritoneal membrane dysfunction and the patient may have fluid overload related complications and have to switch to hemodialysis. Thus, this study aim to enhance our understanding of the protein changes in peritoneal dialysate after the occurrence of peritonitis. In this study, we performed 2DE on 12 pairs of peritoneal dialysate before and after the peritonitis and approximately 400~600 spots were detected. Among these spots, 136 spots were excised, tryptic digested and identified by RP-nano-HPLC-ESI-MS/MS. 41 proteins with high levels of confidence were identified. Among these, ten proteins were significantly differentially expressed in peritoneal dialysate before and after the peritonitis, Western blot and ELISA validation were done. The present study was designed to develop a proteomic map of proteins before and after the peritonitis occurrence. These proteins are not the new biomarkers but they may indicate a situation for possible drug treatment, it may be the predictors of peritonitis which required validation study in future. Pao-Chi Liao 廖寶琦 2013 學位論文 ; thesis 46 en_US
collection NDLTD
language en_US
format Others
sources NDLTD
description 碩士 === 國立成功大學 === 環境醫學研究所 === 101 === Peritoneal dialysis (PD) is one of the therapeutic options for end-stage renal disease (ESRD). The peritoneal membrane is immersed in a high glucose concentration of the peritoneal dialysate which in long term may cause structural and functional damage to the peritoneal membrane. Peritonitis is one of the major complications of PD which will accelerate the damage of peritoneal membrane by increasing the peritoneal permeability and decrease the ultrafiltration efficiency. Finally it will cause the peritoneal membrane dysfunction and the patient may have fluid overload related complications and have to switch to hemodialysis. Thus, this study aim to enhance our understanding of the protein changes in peritoneal dialysate after the occurrence of peritonitis. In this study, we performed 2DE on 12 pairs of peritoneal dialysate before and after the peritonitis and approximately 400~600 spots were detected. Among these spots, 136 spots were excised, tryptic digested and identified by RP-nano-HPLC-ESI-MS/MS. 41 proteins with high levels of confidence were identified. Among these, ten proteins were significantly differentially expressed in peritoneal dialysate before and after the peritonitis, Western blot and ELISA validation were done. The present study was designed to develop a proteomic map of proteins before and after the peritonitis occurrence. These proteins are not the new biomarkers but they may indicate a situation for possible drug treatment, it may be the predictors of peritonitis which required validation study in future.
author2 Pao-Chi Liao
author_facet Pao-Chi Liao
Sing-SingTing
陳成欣
author Sing-SingTing
陳成欣
spellingShingle Sing-SingTing
陳成欣
A comparative proteomics analysis of peritoneal dialysate before and after the occurrence of peritonitis episode by mass spectrometry
author_sort Sing-SingTing
title A comparative proteomics analysis of peritoneal dialysate before and after the occurrence of peritonitis episode by mass spectrometry
title_short A comparative proteomics analysis of peritoneal dialysate before and after the occurrence of peritonitis episode by mass spectrometry
title_full A comparative proteomics analysis of peritoneal dialysate before and after the occurrence of peritonitis episode by mass spectrometry
title_fullStr A comparative proteomics analysis of peritoneal dialysate before and after the occurrence of peritonitis episode by mass spectrometry
title_full_unstemmed A comparative proteomics analysis of peritoneal dialysate before and after the occurrence of peritonitis episode by mass spectrometry
title_sort comparative proteomics analysis of peritoneal dialysate before and after the occurrence of peritonitis episode by mass spectrometry
publishDate 2013
url http://ndltd.ncl.edu.tw/handle/11559201736443628725
work_keys_str_mv AT singsingting acomparativeproteomicsanalysisofperitonealdialysatebeforeandaftertheoccurrenceofperitonitisepisodebymassspectrometry
AT chénchéngxīn acomparativeproteomicsanalysisofperitonealdialysatebeforeandaftertheoccurrenceofperitonitisepisodebymassspectrometry
AT singsingting yǐdànbáizhìtǐxuéjízhìpǔyífēnxīfāngfǎbǐjiàozàifāshēngfùmóyánqiánhòufùmótòuxīyèzhōngdechàyìdànbáizhìbiǎoxiàn
AT chénchéngxīn yǐdànbáizhìtǐxuéjízhìpǔyífēnxīfāngfǎbǐjiàozàifāshēngfùmóyánqiánhòufùmótòuxīyèzhōngdechàyìdànbáizhìbiǎoxiàn
AT singsingting comparativeproteomicsanalysisofperitonealdialysatebeforeandaftertheoccurrenceofperitonitisepisodebymassspectrometry
AT chénchéngxīn comparativeproteomicsanalysisofperitonealdialysatebeforeandaftertheoccurrenceofperitonitisepisodebymassspectrometry
_version_ 1718072430501560320